Explain hypoxia
Reading File
Finding Sources
Searching PubMed
hypoxia pathophysiology mechanisms
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have everything needed for a thorough, well-sourced answer. Let me compose it.
Hypoxia
Hypoxia is a state of decreased oxygen delivery to the tissues, insufficient to meet the metabolic demands of cells. It is distinct from hypoxemia, which specifically means a reduced arterial PO2 - hypoxia is the broader, tissue-level consequence that can occur even when arterial oxygen is normal.
Definition and Core Concept
Oxygen delivery (DO2) to tissues is the product of cardiac output and the oxygen content of blood. The oxygen content of blood depends primarily on hemoglobin concentration and its saturation. Therefore, anything that impairs cardiac output, reduces hemoglobin availability, reduces hemoglobin function, or blocks cellular oxygen utilization can produce hypoxia.
"Hypoxia is decreased O2 delivery to the tissues. Because O2 delivery is the product of cardiac output and O2 content of blood, hypoxia is caused by decreased cardiac output (blood flow) or decreased O2 content of blood." - Costanzo Physiology, p. 247
Types of Hypoxia
The classical four-category framework (from Ganong's and Harrison's) remains the standard clinical reference:
1. Hypoxic (Hypoxemic) Hypoxia
The arterial PO2 itself is reduced. This is the most common form and has several sub-causes:
| Mechanism | Clinical Example |
|---|---|
| Low inspired FiO2 / barometric pressure | High altitude, enclosed spaces |
| Alveolar hypoventilation | Drug overdose, COPD exacerbation, obesity hypoventilation |
| Diffusion impairment | Pulmonary fibrosis, emphysema |
| Ventilation/perfusion (V/Q) mismatch | Asthma, pulmonary embolism, pneumonia |
| Right-to-left shunt | Atelectasis, cyanotic congenital heart disease |
V/Q mismatch is the most common clinical cause of hypoxemia. A right-to-left shunt is notable because it does NOT correct with supplemental oxygen (since blood bypasses ventilated alveoli entirely).
2. Anemic (Hemic) Hypoxia
Arterial PO2 is normal, but oxygen-carrying capacity is reduced. Causes include anemia (low hemoglobin mass) and hemoglobin dysfunction:
- Carbon monoxide (CO) poisoning: CO binds hemoglobin with 200x higher affinity than O2, reducing available binding sites and also shifting the O2-hemoglobin dissociation curve to the left, causing O2 to unload only at lower tissue PO2 values - a double insult.
- Methemoglobinemia: The iron in heme is oxidized to the Fe³⁺ state, which cannot bind O2.
3. Circulatory (Stagnant/Ischemic) Hypoxia
Blood flow to tissues is reduced, so even normal arterial PO2 and hemoglobin content cannot sustain tissue demand. The arterial-venous O2 difference (a-vO2) widens as tissues extract more O2 from sluggish flow. Causes include:
- Heart failure, cardiogenic shock
- Hypovolemic shock, septic shock (microvascular dysfunction)
- Localized arterial obstruction (atherosclerosis, Raynaud's phenomenon)
- Venous obstruction with interstitial edema increasing diffusion distance
4. Histotoxic Hypoxia
Oxygen delivery is adequate, but cells cannot utilize it. O2 accumulates in venous blood (paradoxically high venous PO2). The classic cause is cyanide poisoning, which inhibits cytochrome c oxidase (Complex IV of the mitochondrial electron transport chain), blocking oxidative phosphorylation and ATP production. Other causes: late sepsis, some toxins (via elevated TNF).
"Cyanide and several other similarly acting poisons cause cellular hypoxia by impairing electron transport in mitochondria, thereby limiting oxidative phosphorylation and ATP production. The tissues are unable to use O2, and as a consequence, the venous blood tends to have a high O2 tension. This condition has been termed histotoxic hypoxia." - Harrison's Principles of Internal Medicine, 22nd ed., p. 321
5. Demand (Hypermetabolic) Hypoxia
A fifth category recognized in clinical practice: O2 consumption exceeds delivery even when delivery is normal. Examples: high fever, thyrotoxicosis, seizures, strenuous uncompensated exercise. Clinically, these patients often have warm, flushed skin (from vasodilation dissipating heat) and typically lack cyanosis.
Cellular and Molecular Response: The HIF Pathway
At the cellular level, hypoxia triggers a highly conserved master transcriptional response mediated by Hypoxia-Inducible Factors (HIFs).
- HIFs are heterodimeric transcription factors made up of a labile alpha subunit (HIF-1α, HIF-2α, HIF-3α) and a constitutive beta subunit (HIF-1β).
- Under normoxia, HIF-1α is continuously hydroxylated by prolyl hydroxylase domain proteins (PHDs), then targeted by the von Hippel-Lindau (VHL)-E3 ubiquitin ligase complex for proteasomal degradation. It never accumulates.
- Under hypoxia, PHD activity is suppressed (PHDs require O2 as a substrate). HIF-1α accumulates, dimerizes with HIF-1β, translocates to the nucleus, and binds hypoxia response elements (HREs) on over 100 target genes.
Genes activated by HIFs include:
- Erythropoietin (EPO): stimulates red cell production to increase O2-carrying capacity
- Vascular endothelial growth factor (VEGF): promotes angiogenesis (new blood vessel growth)
- Glycolytic enzymes: shift metabolism from oxidative phosphorylation to anaerobic glycolysis
- Glucose transporters (GLUT1, GLUT3): increase cellular glucose uptake
- Nitric oxide synthase: regulates vascular tone
- Tyrosine hydroxylase: influences carotid body chemoreceptor function
HIF-1α also suppresses mitochondrial function in hypoxia - it diminishes NADH supply to the electron transport chain, induces a subunit switch in Complex IV to optimize efficiency, represses mitochondrial biogenesis, and triggers mitophagy to limit reactive oxygen species (ROS) generation.
"HIF-1α also induces mitochondrial autophagy as an adaptive metabolic response to prevent increased levels of reactive oxygen species (ROS) generation and cell death in hypoxia." - Brenner & Rector's The Kidney
HIF-2α has overlapping but distinct roles. In the kidney, HIF-1α predominates in tubular epithelial cells, while HIF-2α is dominant in interstitial fibroblasts and peritubular endothelium - where it primarily drives EPO production.
Physiological Adaptations to Hypoxia
Acute Responses
- Increased ventilation: hypoxia stimulates peripheral chemoreceptors (carotid and aortic bodies), increasing respiratory rate and depth. This lowers PaCO2 and causes respiratory alkalosis.
- Cerebral vasodilation: reduced PaO2 decreases cerebrovascular resistance, increasing cerebral blood flow to maintain brain O2 delivery. However, if hyperventilation lowers PaCO2 simultaneously, cerebrovascular resistance rises and can worsen cerebral hypoxia.
- Systemic vasodilation: increases cardiac output to improve tissue perfusion. This can precipitate heart failure in patients with underlying cardiac disease.
- Pulmonary vasoconstriction: uniquely, hypoxia causes vasoconstriction in pulmonary vasculature (hypoxic pulmonary vasoconstriction, HPV), diverting blood away from poorly ventilated lung units to improve V/Q matching.
- Anaerobic metabolism: cells switch to glycolysis, producing lactic acid and generating a metabolic acidosis. Lactate accumulates in blood.
- Right shift of O2-Hb curve: acidosis (Bohr effect) shifts the hemoglobin dissociation curve rightward, reducing O2 affinity and facilitating O2 unloading to tissues.
Chronic Responses (Acclimatization)
- Polycythemia: sustained hypoxia drives EPO production (via HIF-2α in renal fibroblasts), increasing red blood cell mass and hemoglobin concentration.
- Increased 2,3-BPG: in red blood cells, causes further right shift of the O2-Hb curve.
- Angiogenesis: via VEGF, more capillaries are formed to reduce diffusion distances.
- Blunted hypoxic ventilatory response: the chemoreceptor response to chronic hypoxia diminishes over weeks (hypoxic ventilatory decline).
At very high altitudes (>4200 m / >13,000 ft), chronic hypoxemia can cause chronic mountain sickness (Monge's disease): blunted respiratory drive, erythrocytosis, cyanosis, pulmonary hypertension, right ventricular enlargement, and cognitive impairment.
Clinical Manifestations
The presentation depends heavily on whether hypoxia is acute or chronic, and how rapidly it develops.
Acute hypoxia signs and symptoms:
- Dyspnea and tachypnea (increased respiratory rate)
- Tachycardia
- Altered mental status: agitation, confusion, delirium, progressing to coma
- Cardiac arrhythmias
- Cyanosis (a late and unreliable sign - often absent in anemia or poor perfusion; detectable when reduced Hb in capillary blood exceeds ~40 g/L)
- Headache, dizziness
Chronic hypoxia: patients often develop remarkable tolerance and may have minimal symptoms despite significant hypoxemia. Polycythemia, clubbing, and pulmonary hypertension may be present.
"Cyanosis is generally a late finding and is often unreliable in diagnosing hypoxia, as it may be absent in the setting of anemia and with poor peripheral perfusion." - Fishman's Pulmonary Diseases and Disorders
Laboratory Assessment
| Test | What it measures | Limitation |
|---|---|---|
| Pulse oximetry (SpO2) | Arterial O2 saturation | Unreliable with CO or methemoglobinemia - use co-oximetry in those cases |
| ABG (PaO2, SaO2) | Arterial O2 tension and saturation | Does not directly measure tissue hypoxia |
| Serum lactate | Anaerobic metabolism marker | Elevated in ischemia/tissue hypoxia |
| Mixed venous O2 sat (SvO2) | Tissue O2 extraction | Low in low-output or ischemic states |
| Hemoglobin/hematocrit | O2-carrying capacity | Important in suspected anemic hypoxia |
Supplemental oxygen is indicated when PaO2 < 60 mmHg or SpO2 < 90% in adults breathing room air (PaO2 < 50 mmHg or SpO2 < 88% in neonates).
Key Distinctions: Hypoxia vs. Hypoxemia
| Hypoxemia | Hypoxia | |
|---|---|---|
| Definition | Low arterial PO2 | Inadequate O2 at tissue level |
| PaO2 | Reduced | May be normal or reduced |
| Scope | Pulmonary/arterial | Systemic/cellular |
| Causes | Lung disease, altitude | Includes cardiac, hematologic, toxic causes |
Hypoxemia is a common cause of hypoxia, but the two terms are not interchangeable.
Sources: Costanzo Physiology 7th ed., Harrison's Principles of Internal Medicine 22nd ed. (2025), Ganong's Review of Medical Physiology 26th ed., Plum & Posner's Diagnosis and Treatment of Stupor and Coma, Fishman's Pulmonary Diseases and Disorders, Brenner & Rector's The Kidney, Morgan & Mikhail's Clinical Anesthesiology 7th ed., Murray & Nadel's Textbook of Respiratory Medicine.
This is a shared conversation. Sign in to Orris to start your own chat.